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ABSTRACT 
Fumarate is an important probe of metabolism in hyperpolarized magnetic resonance imaging and 
spectroscopy. It is used to detect the release of fumarase in cancer tissues, which is associated with 
necrosis and drug treatment. Nevertheless, there are limited reports describing the detailed kinetic 
studies of this enzyme in various cells and tissues. Thus, we aimed to evaluate the sub-minute 
kinetics of human red blood cell fumarase using NMR spectroscopy, and provide a quantitative 
description of the enzyme that is relevant to the use of fumarate as a probe of cell rupture. 
The fumarase reaction was studied using time courses of 1H spin-echo and 13C-NMR spectra. 1H-
NMR experiments showed that the fumarase reaction in hemolysates is sufficiently rapid to make 
its kinetics amenable to study in a period of ~3 min, a timescale characteristic to hyperpolarized 
13C-NMR spectroscopy. The rapid-dissolution dynamic nuclear polarization (RD-DNP) technique 
was used to hyperpolarize [1,4-13C]fumarate, which was injected into concentrated hemolysates. 
The kinetic data were analyzed using recently developed FmRα analysis and modeling the enzyme 
reaction using Michaelis-Menten equations. In RD-DNP experiments, the decline of the 13C-NMR 
signal from fumarate, and the concurrent rise-and-fall of that from malate, were captured with high 
spectral resolution and signal-to-noise ratio, which allowed robust quantification of fumarase 
kinetics. The obtained kinetic parameters indicate the potential contribution of hemolysis to the 
overall rate of the fumarase reaction when 13C-NMR RD-DNP is used to detect necrosis in animal 
models of implanted tumors. The developed analytical procedures will be applicable to studies of 
other rapid enzymatic reactions using conventional and hyperpolarized-substrate NMR 
spectroscopy. 
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INTRODUCTION 
Many biochemical processes in cells occur on the sub-minute timescale, making them notoriously 
difficult to record in situ. NMR spectroscopy has played a central role in our understanding of the 
kinetics of biochemical reactions in intact cells, with human erythrocytes (red blood cells; RBCs) 
being the most extensively studied mammalian cell-type. There are many comprehensive kinetic 
models of enzymatic pathways that were derived using NMR,1-4 but such studies have been 
constrained by the need to acquire the spectral data over prolonged periods of time, with the 
metabolic system already in a quasi-steady state. The advent of rapid dissolution dynamic nuclear 
polarization (RD-DNP) enabled monitoring of metabolic conversions of individual 13C-labeled 
compounds on the sub-minute timescale using 13C-NMR spectroscopy in vivo,5,6 in cell 
suspensions7 or cell lysates, well before an equilibrated state of metabolite concentrations is 
established. 
Fumarase (fumarate hydratase; EC 4.2.1.2) catalyzes the reversible hydration of fumarate to yield 
L-malate: 
   (1) 
where k1 and k-1 signify the apparent rate constants of the forward and reverse reactions, 
respectively. In the history of enzymology, fumarase occupies a special place due to its 
membership of the tricarboxylic acid (Krebs) cycle; accordingly, its reaction mechanism has been 
placed under intense scrutiny.8-10 
Recently, fumarase has assumed a new significance as a diagnostic enzyme for tumor necrosis.11 
It is released into the interstitium of tumor nodules as the central cells become starved of oxygen 
and nutrients when their multiplication rate outstrips that of vascularization, or after the cells die 
from antineoplastic therapy. Since the entry of fumarate into cells is slow (the half-life for transport 
of 26 mM fumarate into RBCs is 11.1 ± 0.4 min),12 the enzymatic conversion of hyperpolarized 
[1,4-13C]fumarate in tumor-bearing mice, as detected on the sub-minute timescale by using RD-
DNP, identifies necrosis in tumors in vivo.11 Thus, it is possible to detect the response of malignant 
COO-
H
Fumarate
k1
k-1
L-Malate
H
H2O
-OOC
COO-
-OOC
HS
HR
OH
H
	 4	
tissues to chemotherapeutic agents, even before any change in the size of the tumor is apparent.13 
The fumarase reaction is well suited for such diagnostic experiments because it is rapid and does 
not require any cofactors, which simplifies its monitoring in cell lysates. 
A notable feature of fumarase biochemistry is that there is only one copy of the corresponding 
gene in the human genome, and yet it has two primary intracellular locations;14,15 one is expectedly 
in the mitochondria where the Krebs cycle is known to operate, and another is in the cytoplasm. 
The enzymes in the two locations are of exactly the same isoform. This raises a question about the 
role of the cytoplasmic enzyme; but, importantly for the present work, it helps explain why RBCs, 
which lack mitochondria, still possess fumarase activity.16,17  
Based on this background knowledge, we aimed to: (a) re-evaluate the in situ kinetics of fumarase 
in freshly prepared human RBCs via time courses of 1H spin-echo NMR spectra,18 in order to 
assess the potential for kinetic characterization using RD-DNP; (b) record time courses in the very 
early stages of the fumarase-catalyzed reaction in hemolysates by using RD-DNP with [1,4-
13C]fumarate; (c) evaluate the performance of our recent FmRα analysis19 to the RD-DNP time 
courses (decay of the fumarate signal and rise-and-fall of the malate signal); and (d) estimate the 
values of the kinetic parameters in the Michaelis-Menten equations, used to model the forward and 
reverse reactions, with a Markov chain Monte Carlo (MCMC) fitting algorithm.20 Such 
information will aid in discussions of the relative contribution of the RBC fumarase released from 
static hemolysed blood in necrotic tissue to that from the host tissue, for example, as occurs in 
tumor nodules after therapy.11 
 
EXPERIMENTAL 
Materials 
All chemicals were purchased from Sigma Aldrich (North Ryde NSW, Australia; or Dorset, UK), 
unless otherwise stated. [1,4-13C]fumaric acid was from Cambridge Isotopes (Tewksbury MA, 
USA). The trityl radical AH111501 was supplied by GE Healthcare (Little Chalfont, UK). The 
gadolinium chelate DOTAREM [Gd3+2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-
1-yl)acetate] was from Guerbet (Paris, France). 
 
RD-DNP sample preparation 
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3.23 mmol of [1,4-13C]fumaric acid was dissolved in 8.60 mmol of DMSO-d6 with 11.8 µmol of 
trityl radical AH111501 and 0.12 µmol of DOTAREM. An 80-mg aliquot of this mixture was 
hyperpolarized using a 3.35 T HyperSense (Oxford Instruments, Abingdon, UK) at a temperature 
of ~1.2 K using microwaves with a frequency of 94.115 GHz and power of 50 mW for up to ~1.5 
h until visible (on the controlling computer screen) saturation of the polarization level. Under 
computer control, the sample underwent rapid dissolution in 6 mL of a solution containing 40 mM 
phosphate, 50 mM sodium chloride, and 40 mM sodium hydroxide (pH 7.4 at 10 bar and 180˚C) 
to give a final fumarate concentration of 39 mM, at pH 7.2. 
 
RBC preparation 
RBCs were obtained by cubital fossa venipuncture from a healthy donor (one of the investigators; 
Human Ethics cleared at all sites) and washing in iso-osmotic phosphate-buffered saline (PBS; 
286 mOsm kg-1, pH 7.25). Collected blood was centrifuged (10 min, 3000g, 4˚C) and the 
supernatant and buffy coat were aspirated and discarded. The process of re-suspension of the cells 
in PBS, centrifugation and supernatant aspiration was repeated twice. For the 1H-NMR 
experiments, the suspensions were bubbled with carbon monoxide for 10 min before the final 
wash. This was done in order to stabilize hemoglobin inside RBCs in a diamagnetic Fe(II) form 
(carboxyhemoglobin) for optimal spectral resolution and signal-to-noise ratio (S/N). After the final 
aspiration of the supernatant, the volume fraction of cells in the sample (hematocrit; Ht) was 
estimated and used in subsequent calculations; it was typically 80-87%. In experiments with 
hemolysates, RBC suspensions were subjected to two cycles of freezing in liquid nitrogen and 
thawing at ~30˚C. The samples were used for NMR measurements on the same day. 
 
NMR spectroscopy 
1H-NMR spectra were recorded at 400.13 MHz on a Bruker (Karlsruhe, Germany) Avance III 
console with a 9.4 T vertical wide-bore magnet from Oxford Instruments (Oxford, UK), equipped 
with a 10-mm Bruker broadband (BBO) probe. 
2.0 mL of freshly prepared hemolysate was added to a 10-mm NMR tube and thermally pre-
equilibrated at 37˚C inside the spectrometer bore. Then, 1.0-2.0 mL of sodium fumarate solution 
in PBS (pH 7.2) was injected rapidly via a heat-exchanging system designed to pre-equilibrate the 
fumarate solution to 37˚C, with subsequent mixing.21 
	 6	
Monitoring the fumarase reaction by recording sequential NMR spectra was started at the time of 
the injection. Single-transient 1H spin-echo NMR spectra18 were acquired every 5 s over a duration 
of ~20 min using a 90˚ pulse of 29 µs, spectral width of 4 kHz, 4096 complex points, acquisition 
time of 1.024 s, and spin-echo delay τ = 291 ms, which corresponded to a total echo duration of 
582 ms. In the experiments with the whole RBCs, the spin-echo delay was shortened to 190 ms. 
13C-NMR spectra were recorded on a Bruker Avance II 600 MHz spectrometer (150.9 MHz for 
13C) with a 14.1 T vertical magnet using a 10-mm Bruker broadband probe. The 13C-NMR RD-
DNP experiments involved injecting 2.0 mL of hyperpolarized [1,4-13C]fumarate solution via the 
37˚C heat-exchanger into a 10-mm NMR tube in the probe of the NMR spectrometer. The sample 
tube contained 2.0 mL of hemolysate that had been thermally equilibrated at 37˚C. 
 
Data processing and analysis 
All NMR spectra were processed using TopSpin 3.5 (Bruker); they were extracted as text files and 
read into Mathematica22 programs. The spectra were phase corrected and baseline adjusted prior 
to analysis; exponential window functions with line broadening factors of 5.0 Hz and 10.0 Hz were 
used in the processing of 1H and 13C spectra, respectively. In some instances, several initial spectra 
showed inconsistent intensities due to incomplete sample mixing so they were discarded from the 
analysis. 
The following kinetic modeling was based on the reaction time courses (temporal evolution of the 
fumarate and malate signals), which were processed by measuring the integrals of the 
corresponding peaks in each of the spectra, and then converting these values into respective 
concentrations, as described below.  
In 1H-NMR time courses, the single fumarate peak and the negative sum of the two malate peak 
integrals (3HR and 3HS) were used for the concentration calculations. Due to the phase modulation 
brought about by 1H-1H J-couplings, the ratio of the intensities of the fumarate and malate 
resonances did not reflect the correct ratio of their concentrations. Therefore, the latter values of 
fumarate and malate were obtained by deriving the two coefficients of proportionality between the 
measured integrals and the concentrations. These coefficients were obtained by a least-squared fit 
that optimized the condition of the sum of the two concentrations being as close as possible to the 
originally injected amount of fumarate (11.4 mM or 22.8 mM) for each point in the time course. 
Concentrations of endogenous fumarate and malate in blood are in the micromolar range,23,24 thus 
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their contributions to the NMR signals were taken to be negligible. The obtained 1H-NMR time 
course data were analyzed by regressing the numerical solution of the Michaelis-Menten equations 
in Mathematica using the function NonlinearModelFit. 
In 13C-NMR experiments, single-transient pulse-and-acquire spectra were obtained every 1 s for 
256 s, using a small (~4˚) flip-angle pulse, spectral width of 40.65 kHz, 32768 complex points, 
and acquisition time of 0.806 s. Time courses of the 13C-NMR signal intensities were constructed 
from the corresponding peak integrals. Only hyperpolarized NMR signals from fumarate and 
malate (Fum* and Mal*; see below) are observable in these spectra. Thus, the concentration of 
hyperpolarized fumarate [Fum*] was calculated for each point in the time course by assuming that 
the initial value of the curve, fitted to the peak-integral data, corresponded to the initial total 
concentration of fumarate that was known from the sample preparation. For calculation of the 
concentration of the hyperpolarized malate [Mal*], the integrals of the two peaks, corresponding 
to the inequivalent positions C1 and C4, were summed and these integral values were scaled by 
the same factor as those of fumarate. 
The 13C-NMR RD-DNP data were studied using FmRα analysis to obtain initial estimates of the 
kinetic and relaxation rate constants. Next, the obtained estimates were used as starting parameter 
values in an MCMC method for fitting the mathematical representation of the fumarase reaction 
(see below). The application of a small flip-angle excitation pulse was built into the model to 
account for losses of signals due to the readout of the magnetizations at each time step. Our 
implementation of the MCMC algorithm was previously described in detail.20,25,26. 
 
RESULTS 
1H NMR of hemolysates 
Figure 1 shows a stacked plot of typical 1H spin-echo NMR spectra obtained upon addition of 
fumarate to a hemolysate, along with the corresponding spectral assignments. Fumarate injection 
resulted in the immediate appearance of a singlet at 6.49 ppm, corresponding to the two equivalent 
hydrogen atoms of fumarate (2H and 3H). Subsequently, the conversion of fumarate into malate 
was evidenced by the decline of the fumarate signal and appearance of three peaks, corresponding 
to the three inequivalent hydrogen atoms of malate: 2H (4.27 ppm), 3HR (2.64 ppm) and 3HS (2.33 
ppm). The peaks corresponding to 3HR and 3HS had negative intensities due to the 1H-1H J-
coupling modulations for the chosen value of the delay τ (291 ms) in the spin-echo experiment. 
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The peak at 1.30 ppm was assigned to 3H of lactate, which is present due to the ongoing glycolytic 
pathway from endogenous 2,3-biphosphoglycerate (23BPG). No other metabolites were seen in 
the spectra. 
Figure 2 shows resultant time courses obtained upon injection of fumarate into hemolysates (for 
two final concentrations of fumarate: 22.8 or 11.4 mM). In the case of 11.4 mM fumarate, the 
equilibrium was reached after ~500 s (the curves reached a plateau), while it took approximately 
twice as long for equilibration when the amount of injected fumarate was doubled (22.8 mM). 
From the two time courses of Figure 2, the equilibrium constant !"# = [&'(]*+[,-.]*+	 was estimated to 
be 2.4 ± 0.1, where [Mal]"# and [Fum]"# are the equilibrium molar concentrations of malate and 
fumarate, respectively. 
In the case of 22.8 mM fumarate, the initial part of the time course (first ~36 transients) was linear, 
which indicated full saturation of the enzyme at this high substrate concentration; in other words, 
this resulted in pseudo zero-order kinetics due to the near-constant reactant concentrations 
(fumarate and water). Fitting a straight line through the initial linear part of the time course allowed 
us to calculate the rate of fumarate conversion: 2.0 ± 0.1 mM min-1, which corresponded to 4.6 ± 
0.3 mmol (L RBC)-1 min-1 when normalized by the volume of cells in the sample. This implied 
that a significant fraction of the ~10-20 mM hyperpolarized [1,4-13C]fumarate, injected into a 
concentrated hemolysate, would be converted to L-malate in the ~3 min available in an 13C-NMR 
RD-DNP experiment. 
 
Modeling of 1H-NMR time courses 
Kinetic modeling of the experimental 1H spin-echo time courses was based on the steady-state 
(with respect to the concentration of the enzyme-substrate complex) Michaelis-Menten equations, 
modified to account for competition between fumarate and malate for the active site in the enzyme. 
The concentration of the enzyme-substrate complex reaches a steady state within milliseconds for 
most enzymes,27 so the Michaelis-Menten model remains fully valid (even in the case of RD-DNP 
analysis – see below). The differential equations that describe the kinetics of the reversible reaction 
of Equation 1 are: 	6[,-.]67 = −9:[Fum] + 9<:[Mal]        (2)	
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6[&'(]67 = −9<:[Mal] + 9:[Fum]        (3)		
where [Fum] and [Mal] denote current (at a given time) molar concentrations of fumarate and 
malate, and the apparent unidirectional rate constants 9: and 9<: apply to the forward and reverse 
reactions of Equation 1, respectively. According to the Michaelis-Menten model taking into 
account product inhibition,28 these rate constants are, in turn, functions of the concentrations of 
fumarate and malate: 
 9: = =>?@AB>C>AB>D:E[F?G]H>F?GIE[,-.]         (4) 9<: = =>?@F?GC>F?GD:E[AB>]H>AB>IE[&'(]         (5) 
 
Where J.'K,-.  and J.'K&'(  are the maximum velocities of the forward and reverse reactions of 
Equation 1, respectively; !.,-. and !.&'( are the respective Michaelis constants of fumarase for 
fumarate and malate. 
After the expressions of Equations 4-5 were substituted into Equations 2-3, the differential 
equations were solved numerically in Mathematica. The solutions of these equations were 
regressed onto the two experimental time courses of Figure 2 to estimate the values of the 
Michaelis-Menten parameters and the equilibrium constant !"#, which, in turn, bears the following 
fundamental relationship with the Michelis-Menten parameters:8 
 !"# = [&'(]*+[,-.]*+ = C>F?G	=>?@AB>C>AB>	=>?@F?G	 	 	 	 	 	 	 	 	 (6) 
 
In preliminary trial fits, it became evident that we could obtain equally good fits with various Km 
values below ~1 mM. This implied the Michaelis constants of fumarase for fumarate and malate 
were in the micromolar range and, as the substrate concentrations used were all above 1 mM, the 
enzyme was effectively fully saturated at any time point in the reaction. Since the inherently low 
sensitivity of NMR spectroscopy would not allow measurements with substrate concentrations 
below 1 mM, we did not have the requisite information in the fitting curves to allow us to 
	 10	
reliably the Km values in the micromolar range. Nevertheless, we proceeded with fitting of the 
available data by setting the starting values of !.,-. and !.&'( to 5.0 and 25.0 µM, respectively, 
as reported by Teipel et al.10 The simultaneous fit of the two time-courses shown in Figure 2 
yielded the following estimates of the Michaelis-Menten parameters: 	J.'K,-. = 5.9 ± 0.3 mmol (L 
RBC)-1 min-1;		J.'K&'( = 16.0 ± 0.6 mmol (L RBC)-1 min-1;	!.,-. = 3.9 ± 0.3 µM;	!.&'( = 25.6 ± 1.0 
µM; and !"# = 2.4 ± 0.3, calculated using Equation 6. 
 
1H NMR of whole RBCs 
Additionally, we investigated the rate of the fumarase reaction upon addition of fumarate to whole 
intact red blood cells. These experiments were conducted in the same way as the experiments with 
the hemolysates: 2.0 mL of a fumarate solution was injected into 2.0 mL of RBC suspension. In 
contrast to the hemolysate experiments, there was no evidence of the appearance of the malate 
peaks in the initial 10 min after commencing acquisition of the 1H spin-echo NMR spectra (Figure 
3). This was concluded to be because fumarase was initially located only inside the cells, and, 
since fumarate penetrates the plasma membrane of RBCs very slowly,12 there was only very 
limited access of the injected fumarate to fumarase and hence a lack of reaction. 
Having demonstrated no fumarase activity in the time course with whole RBCs for ~10 min, we 
injected 1.0 mL of the surfactant, Triton X-100, into the reaction medium via the same heat-
exchange system that provided vigorous mixing. After this event, the conversion of fumarate to 
malate became evident (Figure 3). 
In comparison with a typical hemolysate experiment (Figure 1), the spectral S/N was much poorer 
when intact RBCs were present; this was due to endogenous magnetic field gradients that they 
induce.29 In order to obtain better S/N in the initial spectra, when samples consisted mostly of 
whole cells, we used a shorter spin-echo delay (τ = 190 ms). As the cells were being lysed in the 
presence of the surfactant, the S/N grew significantly. Therefore, for clarity of Figure 3, the 
amplitude of the fumarate peak was adjusted to be the same in all shown spectra. Shortening the 
spin-echo delay τ resulted in an altered pattern of signs of the malate peak intensities (Figure 3), 
due to the different modulation of the resonances by 1H-1H J-couplings. It was clear that, upon 
lysis of RBCs by the surfactant, the production of malate was substantially faster than in whole 
cells. 
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This experiment modeled the in vivo situation of fumarase release during necrosis/hemolysis in 
tumors. Thus, when fumarate is used as the ‘pathological-state detection substrate’,11 the 
appearance of the malate signal could be due to ruptured RBCs in tumor nodules, in addition to 
lysed cancer cells. 
 
13C-NMR RD-DNP time courses 
Figure 4 shows a stacked plot consisting of sequential 13C-NMR spectra, obtained after injecting 
2.0 mL of hyperpolarized [1,4-13C]fumarate solution into 2.0 mL of a hemolysate, leading to a 
final substrate concentration of 22.2 mM and Ht = 42.5%. Injection of the hyperpolarized fumarate 
resulted in a strong 13C-NMR resonance at 176.1 ppm. The intensity rapidly declined with a 
concurrent rise-and-fall of the resonances from [1,4-13C]malate, at 182.5 and 181.3 ppm (Figure 
4). As illustrated in Figure 5, the intensity of the malate resonance reached a maximum at tmax = 
~20 s and it was smaller by a factor of ~100 than the starting intensity of the fumarate resonance. 
Both resonances had declined into the noise ~120 s after the injection. 
 
13C-NMR RD-DNP - FmRα analysis 
Initially, time courses of 13C-NMR RD-DNP spectra were analyzed using our recently developed 
FmRα analysis.19 Figure 5 shows the application of this method to the time course of 13C-NMR 
signal intensities of fumarate and malate, obtained using the spectra of Figure 4. Estimates of T1 
and the kinetic constant k1 were made as follows. The ratio of the peak amplitude of the product 
and substrate at time tmax (denoted by ‘Pmax’ and ‘S[tmax]’ in Figure 5, respectively), gave the value 
of β = 0.025 (noting that the intensity of the product was scaled up by a factor of 20). FmRα is the 
time-span of the horizontal line (green arrow) drawn at height α (88% of the maximum amplitude 
of the product’s rise-and-fall curve).19 According to the theory, this time corresponds to the average 
T1 value of the two reactants; it was estimated to be ~18 s. The estimate of the apparent first-order 
rate constant k1 that characterizes the reaction kinetics is given by β/T1 = ~1.4 × 10-3 s-1. Therefore, 
the initial reaction velocity, calculated as the value of k1 multiplied by the initial fumarate 
concentration (and normalized to Ht = 100%) was 22.2 mM ´ 1.4 × 10-3 s-1 / 0.425 = 0.073 mmol 
(L RBC)-1 s-1 or ~4.4 mmol (L RBC)-1 min-1. This value is in a very good agreement with the value 
of the initial flux of the reaction calculated by using 1H-NMR time courses (see above). 
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13C-NMR RD-DNP - MCMC analysis 
Using the values of the kinetic and relaxation rate constants obtained via the FmRα analysis as the 
initial estimates, a more comprehensive kinetic characterization of the reaction was implemented 
using MCMC fitting of the Michaelis-Menten model to the experimental 13C-NMR time courses. 
The model was based on a set of four coupled linear differential equations that describe the time 
evolution of the concentrations of the 13C-labeled reactants involved in the reaction. As described 
previously,21,30,31 each molecular species undergoing physical/chemical transformations in the RD-
DNP experiments, might be conceptually split into two pools: hyperpolarized (or ‘labeled’) and 
non-hyperpolarized, with only the hyperpolarized species contributing to the detectable signal. The 
relevant kinetic scheme, which forms the basis for formulating the following kinetic equations, is 
shown in Figure 6; it leads to a system of four coupled differential equations: 
 6[,-.∗]67 = − :MNAB> [Fum∗] − 9:[Fum∗] + 9<:[Mal∗]	 	 	 	 	 	 (7) 
 6[,-.]67 = :MNAB> [Fum∗] − 9:[Fum] + 9<:[Mal]	 	 	 	 	 	 (8) 
 6[&'(∗]67 = − :MNF?G [Mal∗] − 9<:[Mal∗] + 9:[Fum∗]      (9) 
 6[&'(]67 = :MNF?G [Mal∗] − 9<:[Mal] + 9:[Fum]       (10) 
 
where the asterisks denote the hyperpolarized species. The values of T1 apply to fumarate (Fum) 
and malate (Mal), and the apparent unidirectional rate constants k1 and k-1 characterize the flux in 
the forward and reverse reactions, as shown in Equation 1. While these equations are the basis of 
the FmRα analysis, they disregard the Michaelis-Menten nature of the kinetic processes; and it 
transpired that they did not lead to good fits to the experimental data shown in Figure 7A. Hence, 
the differential equations were further expanded to account for the effects of product 
inhibition/competition (see below), which allowed us to obtain a more comprehensive and 
statistically robust fit of the model to the experimental data. 
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According to the Michaelis-Menten model, the apparent unidirectional rate constants in Equations 
7-10 can be expressed in terms of concentrations of the two competing substrates; however, a 
subtle point worth noting is that these concentrations must contain the sums of both hyperpolarized 
and non-hyperpolarized species: 
 9: = =>?@AB>C>AB>D:E[F?G]O[F?G∗]H>F?G IE[,-.]E[,-.∗]       (11) 
 9<: = =>?@F?GC>F?GD:E[AB>]O[AB>∗]H>AB> IE[&'(]E[&'(∗]       (12) 
 
where, as before, the asterisks denote the hyperpolarized species; the maximal velocities J.'K,-. and J.'K&'(  apply to the forward (Fum) and reverse (Mal) reactions of Equation 1, respectively, as do the 
respective Michaelis constants !.,-. and !.&'(. 
Substitution of Equations 11-12 into Equations 7-10 allows us to obtain a set of differential 
equations that accounts for the reaction kinetics with the possibility of enzyme saturation and 
variable kinetic order that depends on reactant concentration: 
 6[,-.∗]67 = − [,-.∗]MNAB> − =>?@AB>[,-.∗]C>AB>D:E[F?G]O[F?G∗]H>F?G IE[,-.]E[,-.∗] + =>?@F?G[&'(∗]C>F?GD:E[AB>]O[AB>∗]H>AB> IE[&'(]E[&'(∗] (13) 6[,-.]67 = [,-.∗]MNAB> − =>?@AB>[,-.]C>AB>D:E[F?G]O[F?G∗]H>F?G IE[,-.]E[,-.∗] + =>?@F?G[&'(]C>F?GD:E[AB>]O[AB>∗]H>AB> IE[&'(]E[&'(∗] (14) 6[&'(∗]67 = − [&'(∗]MNF?G − =>?@F?G[&'(∗]C>F?GD:E[AB>]O[AB>∗]H>AB> IE[&'(]E[&'(∗] + =>?@AB>[,-.∗]C>AB>D:E[F?G]O[F?G∗]H>F?G IE[,-.]E[,-.∗] (15) 6[&'(]67 = [&'(∗]MNF?G − =>?@F?G[&'(]C>F?GD:E[AB>]O[AB>∗]H>AB> IE[&'(]E[&'(∗] + =>?@AB>[,-.]C>AB>D:E[F?G]O[F?G∗]H>F?G IE[,-.]E[,-.∗] (16) 
 
Thus, the numerical solutions of Equations 13-16 were fitted using the MCMC algorithm to the 
experimental 13C-NMR time courses. The MCMC analysis performed well in terms of generating 
reproducible estimates of the fitted parameters, once the parameter space had been restricted by 
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fixing the values of α (the flip-angle of the magnetization-sampling radiofrequency pulse) to 4˚, 
and previously determined equilibrium constant Keq to 2.4. Thus, only the maximal velocities, 
Michaelis constants, T1 values and the initial concentration of the hyperpolarized fumarate 
[Fum*](0) were floated. Fitting systematically gave values of the order of 1 mM for !.,-. and !.&'(. Since the reaction was studied at supra-physiological substrate concentrations, the enzyme 
would be expected to be fully saturated for the whole time over which the reaction was able to be 
monitored. This meant that the values of the Michaelis constants could not be reliably estimated. 
Thus, the value of !.,-. was fixed at 3.9 µM (value, obtained from fitting of the 1H-NMR data), 
while the value of !.&'( was automatically calculated at each time step using Equation 6. 
Figure 7A shows an MCMC fit to the data obtained using the time-course data of Figure 5. The 
robustness of the MCMC fits in the context of modeling the fumarase reaction was assessed 
using a statistical ‘sensitivity analysis’.32 This entailed random variation of the parameter values, 
and accepting only those changes to the ‘parameter chain’ that led to a deacrease or an 
insignificant increase in the fit score (calculated as the root mean square deviation (RMSD) 
between the experimental and simulated time-course curves). The process of the variation of the 
parameter values was repeated for 20,000 iterations and the RMSD criterion was adjusted so that 
the acceptance rate was ~35%. This procedure allowed us to generate arrays of numerical values 
for each of the fitted parameters, which were used to visualize their dispersions, as shown in 
Figure 7B for P:,-., P:&'(, J.'K,-. and [Fum*](0). Based on the obtained near-Gaussian 
distributions (Figure 7B), the means and standard deviations for each of the parameters were 
calculated. The analysis resulted in the following estimated values of parameters (after 
constraining α = 4o, Keq = 2.4, !.,-. = 3.9 µM): P:,-. = 20.7 ± 0.5 s; P:&'( = 19.1 ± 3.4 s; J.'K,-. 
= 4.0 ± 0.8 mmol (L RBC)-1 min-1; J.'K&'( = 13.0 ± 4.7 mmol (L RBC)-1 min-1; and initial 
concentration of [Fum*](0) = 20.9 ± 0.3 mM. 
 
DISCUSSION 
1H-NMR time courses 
The 1H-NMR time courses (Figure 2) showed that the rate of the fumarate-to-malate conversion 
in hemolysates was close to that reported by Simpson et al.12 In this previous work, the half-life of 
conversion of 30 mM fumarate (in a hemolysate of Ht = 83%) was ~3 min. A detailed kinetic 
characterization of RBC fumarase was not the aim of that work; nevertheless, the maximum flux 
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measured in our work (4.6 ± 0.3 mmol (L RBC)-1 min-1) corresponded to conversion of 11.5 mM 
of fumarate in 3 min in a hemolysate of Ht = 83%, while it would have implied conversion of 15 
mM fumarate using the previously reported rate.12 The experimental conditions differed in both 
projects, especially the freshness of the hemolysates, so a comparison must be made cautiously. 
Nevertheless, estimating a reaction rate to within a factor of ~1.5 of the previous work was 
encouraging for the next series of measurements. Importantly, the rates estimated from the 1H-
NMR experiments indicated that the fumarase reaction in hemolysates was sufficiently rapid to be 
characterized successfully by the 13C-NMR RD-DNP experiments, the latter being especially 
useful for the kinetic characterization of metabolic processes in vivo. 
Theoretically, malate can be further converted in RBCs to oxaloacetate, pyruvate and lactate.12 
This pathway occurs via oxidation of malate by malate dehydrogenase (EC 1.1.1.37) and requires 
significant levels of free NAD+/NADH in the system. However, in hemolysates most of the free 
NAD+/NADH is destroyed by contact with the NAD(P)+ nucleosidase (EC 3.2.2.6) which is 
located on the cell exterior.33 Thus, the rate of malate to lactate conversion in hemolysates was 
reported to be negligible when no external NAD+ is added to the sample,12 and we concluded that 
the lactate seen in our spectra (Figure 1) was produced via glycolysis from 23BPG. 
The equilibrium constant of the fumarase reaction (Keq) was previously shown to be a function of 
the ionic strength of the medium, temperature, and pH.8,34 Bock and Alberty reported Keq = ~4.8 
at an ionic strength of 0.50 M, pH 7.3 and 25˚C, while Scott and Powell reported Keq = 3.8 under 
the same buffer conditions.34 Our value of Keq = 2.4 is closer to the value of 3.1, reported by 
Borsook and Schott,35 while the Michaelis constant of fumarase for fumarate (3.9 ± 0.3 µM) and 
malate (25.6 ± 1.0 µM) are in agreement with the literature values.10 
 
13C-NMR RD-DNP time courses 
The observed decay of the 13C-NMR RD-DNP fumarate signal and the concurrent rise-and-fall of 
that of malate were conveniently suitable for the application of the FmRα analysis.19 The initial 
velocity of the reaction, computed using this procedure (4.4 mmol (L RBC)-1 min-1), was very 
similar to that estimated from our 1H-NMR data (4.6 ± 0.3 mmol (L RBC)-1 min-1). Note that this 
rate is ~150 times faster than RBC glycolysis,1 so fumarase activity in human RBCs is indeed very 
high in comparison with the ‘housekeeping’ carbon flux. 
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The four first-order differential equations (Equations 13-16) constitute a minimalist model of 
fumarase as a reversible Michaelis-Menten enzyme. The magnetization-relaxation part of these 
equations (formally called the Bloch-McConnell equations) is represented by first-order decay 
terms, characterized by the relaxation time constants (T1), while the chemical exchange parts are 
derived from the steady-state Michaelis-Menten equation. An important subtlety in formulating 
these chemical-exchange equations is that the denominators in the expressions for rate constants 
must contain the sums of the concentrations of all of the relevant species, whether hyperpolarized 
or not, because it is the total chemical potential of the species that drives the chemical exchange 
reaction (mediated by fumarase in this case). 
The Michaelis constants of fumarase are known to be in the micromolar range,10 but the inherently 
low sensitivity of the NMR techniques requires the use of substrate concentrations at least in the 
millimolar range. This meant that the kinetics of the fumarase reaction was virtually zero-order 
upon the initial injection of fumarate. However, as the product of the reaction (malate) was being 
accumulated, the reaction was increasingly subjected to product inhibition, according to the ratio 
of the two Michaelis constants and maximum velocities. 
Estimated maximum velocities of the reaction in the forward and reverse direction were found to 
be 4.0 ± 0.8 and 13.0 ± 4.7 mmol (L RBC)-1 min-1, respectively; these values were slightly lower 
that the corresponding estimates from the 1H-NMR measurements: 5.9 ± 0.3 and 16.0 ± 0.6 mmol 
(L RBC)-1 min-1. Since the donor for each of the experiments was the same person, biological 
variability was not the basis of this finding. Additionally, the stability of the linewidth and 
chemical shifts of all the peaks in both 1H- and 13C-NMR time course data indicated that the 
temperature was well-equilibrated across the sample before the acquisition of the NMR data began. 
Therefore, we concluded that variability in the estimates of the kinetic parameters between the 1H 
and 13C-NMR data was not caused by gradients in the sample temperature. 
Nevertheless, there were some differences in the chemical composition of the media between the 
1H and 13C-NMR experiments, which were unavoidable due to the specific requirements for the 
preparation of the hyperpolarized samples. Specifically, the trityl radical DOTAREM and solvent 
DMSO were present in the samples for the RD-DNP experiments. Although the final 
concentrations of these compounds were small, we cannot rule out the possibility of them having 
an effect on the fumarase reaction. Phosphate, on the other hand, is a known effector of fumarase 
(activating reagent). After the volume of the sample occupied by the cells was taken into account, 
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the final concentration of phosphate in the NMR sample, in the 1H spin-echo and 13C RD-DNP 
experiments, was 5.75 and 20.75 mM, respectively. According to Table 1 of Massey,36 the relative 
activity of fumarase at pH 7.4 in the former case would be ~54 activity units, compared with ~56 
activity units in the latter. Thus, the effect of our particular phosphate concentration was deemed 
to be non-significant (~3-4% variation) and would not fully account for the observed difference in 
the fumarase activity. 
The estimates of T1 values were in good agreement among the two methods used to obtain them: 
~18 s (FmRα); P:,-.  = 20.7 ± 0.5 s and P:&'(  = 19.1 ± 3.4 s (MCMC). These values also 
corresponded well to those previously obtained by Gallagher et al.11 using a similar methodology 
to ours: P:,-. = 24.1 ± 2.1 s and P:&'( = 18.4 ± 7.0 s. 
 
Implications for in vivo studies 
While our 1H-NMR study demonstrated that the equilibration of the fumarase reaction occurred 
over a time domain of ~20 min (after initial injection of 22.8 mM fumarate), the counterpart 13C-
NMR RD-DNP experiment allowed us to monitor the reaction only for the initial ~100 s after 
injection. Thus, an extent of the fumarase reaction only up to ~8-10% was able to be monitored in 
the latter experiment. It is the rapid decay of the nuclear polarization (according to the T1 values 
of metabolites) that limits the time domain over which the 13C RD-DNP technique is applicable.  
Gallagher et al.11 reported k1 = 0.018 s-1 in drug-treated tumors. Assuming that there was ~10% of 
blood by volume, Ht of ~50%, and the tumor size was ~2 cm3,37 there would be ~10-4 L of RBCs 
in the tumor. According to the estimates of J.'K,-. reported here, in the case of 100% hemolysis, 
this would correspond to maximum reaction flux of 0.03 mmol s-1 in the forward direction. Given 
that the amount of injected fumarate was 3.23 mmol,11 the reaction rate constant k1 due the RBC 
fumarase could be as high as 0.009 s-1, or half of the rate constant observed in tumor-bearing 
mice.11 
Thus, we deduce that the capacity of the fumarase-catalyzed reaction in RBCs is so high that 
hemolysed RBCs could contribute significantly to the overall metabolism of [1,4-13C]fumarate in 
necrotic tumors in vivo. As a proof-of-principle, this was demonstrated using the experiment with 
a detergent that lysed the RBCs and released fumarase into the extracellular medium (Figure 3). 
Even though neoplastic formation is not typically associated with hemolysis, there are at least three 
factors which might mediate the rupture of RBCs in a tumor: autoimmune processes (autoimmune 
	 18	
hemolytic anemia),38 microangiopathic disorders38-41 and chemotherapy.38,42,43 The deduction 
about the contribution of ruptured RBCs to the fumarase reaction in necrotic tissues awaits 
verification, by making measurements on tumor tissue or cancer-cell suspensions in vitro. The 
NMR and data-analysis methodologies developed here will be beneficial for these future studies. 
 
Conclusions and future directions 
We conducted 1H spin-echo and 13C RD-DNP NMR studies of human red blood cell fumarase in 
hemolysates and whole cells using injections of exogenous fumarate. We demonstrated that, in 
both experiments, the kinetics of the fumarase reaction could be quantified by fitting a 
mathematical model to the reaction time course data. To our knowledge, a detailed in situ (in vitro) 
study of the RBC fumarase kinetics is reported here for the first time. The estimated rate of the 
reaction was in the range 4-6 mmol (L RBC)-1 min-1, which was sufficiently high to enable the 
kinetic characterization of the enzyme with 13C-labeled fumarate in RD-DNP experiments. High 
fumarase activity in RBCs indicates a potential contribution of hemolysis to measurements of the 
extent of necrosis in tumors in vivo by using hyperpolarized fumarate. The experimental (NMR) 
and Mathematica-based procedures for data analysis developed here have them poised for 
applications to the kinetic characterization of other enzymes in cell lysates, whole cells, and 
tissues. 
 
ACKNOWLEDGEMENTS 
The work was funded by a Discovery Project Grant from the Australian Research Council to PWK 
(DP140102596), and a European Research Council (ERC) grant to GP. The Leverhulme Trust 
supported a Visiting Professorship for PWK in the Group of Professor Malcolm Levitt and GP in 
the School of Chemistry at the University of Southampton. Work in K.M. Brindle’s laboratory is 
supported by a Cancer Research UK Programme grant (17242) and the CRUK-EPSRC Imaging 
Centre in Cambridge and Manchester (16465). 
  
	 19	
REFERENCES 1.	 Mulquiney	PJ,	Bubb	WA,	Kuchel	PW.	Model	of	2,3-bisphosphoglycerate	metabolism	in	the	 human	 erythrocyte	 based	 on	 detailed	 enzyme	 kinetic	 equations:	 in	 vivo	 kinetic	characterization	of	2,3-bisphosphoglycerate	synthase/phosphatase	using	13C	and	31P	NMR.	Biochem	J	1999;342:567-580.	2.	 Mulquiney	 PJ,	 Kuchel	 PW.	 Model	 of	 2,3-bisphosphoglycerate	 metabolism	 in	 the	human	erythrocyte	based	on	detailed	enzyme	kinetic	equations:	equations	and	parameter	refinement.	Biochem	J	1999;342:581-596.	3.	 Mulquiney	 PJ,	 Kuchel	 PW.	 Model	 of	 2,3-bisphosphoglycerate	 metabolism	 in	 the	human	erythrocyte	based	on	detailed	enzyme	kinetic	equations:	computer	simulation	and	metabolic	control	analysis.	Biochem	J	1999;342:597-604.	4.	 Kuchel	 PW,	Mulquiney	 PJ.	 Combined	NMR	 experimental	 and	 computer-simulation	study	of	2,3-bisphosphoglycerate	metabolism	in	human	erythrocytes.	In:	Cornish-Bowden	A,	Cárdenas	ML,	editors.	Technological	and	medical	implications	of	metabolic	control	analysis.	Dordrecht:	Springer	Netherlands;	2000.	p.	139-145.	5.	 Nelson	SJ,	Kurhanewicz	 J,	Vigneron	DB,	Larson	PEZ,	Harzstark	AL,	Ferrone	M,	van	Criekinge	M,	Chang	JW,	Bok	R,	Park	I,	Reed	G,	Carvajal	L,	Small	EJ,	Munster	P,	Weinberg	VK,	Ardenkjaer-Larsen	 JH,	Chen	AP,	Hurd	RE,	Odegardstuen	L-I,	Robb	FJ,	Tropp	 J,	Murray	 JA.	Metabolic	imaging	of	patients	with	prostate	cancer	using	hyperpolarized	[1-13C]pyruvate.	Sci	Transl	Med	2013;5:198ra108.	6.	 Ardenkjær-Larsen	JH,	Fridlund	B,	Gram	A,	Hansson	G,	Hansson	L,	Lerche	MH,	Servin	R,	Thaning	M,	Golman	K.	 Increase	 in	signal-to-noise	ratio	of	>10,000	times	 in	liquid-state	NMR.	Proc	Natl	Acad	Sci	U	S	A	2003;100:10158-10163.	7.	 Jensen	PR,	Karlsson	M,	Lerche	MH,	Meier	S.	Real-time	DNP	NMR	observations	of	acetic	acid	 uptake,	 intracellular	 acidification,	 and	 of	 consequences	 for	 glycolysis	 and	 alcoholic	fermentation	in	yeast.	Chem	-	Eur	J	2013;19:13288-13293.	8.	 Bock	RM,	Alberty	RA.	Studies	of	the	enzyme	fumarase.	I.	Kinetics	and	equilibrium.	J	Am	Chem	Soc	1953;75:1921-1925.	9.	 Brant	DA,	Barnett	LB,	Alberty	RA.	The	temperature	dependence	of	the	steady	state	kinetic	parameters	of	the	fumarase	reaction.	J	Am	Chem	Soc	1963;85:2204-2209.	10.	 Teipel	 JW,	 Hass	 GM,	 Hill	 RL.	 The	 substrate	 specificity	 of	 fumarase.	 J	 Biol	 Chem	1968;243:5684-5694.	11.	 Gallagher	FA,	Kettunen	MI,	Hu	D-E,	Jensen	PR,	in	't	Zandt	R,	Karlsson	M,	Gisselsson	A,	Nelson	 SK,	 Witney	 TH,	 Bohndiek	 SE,	 Hansson	 G,	 Peitersen	 T,	 Lerche	 MH,	 Brindle	 KM.	Production	of	hyperpolarized	[1,4-13C2]malate	 from	[1,4-13C2]fumarate	 is	a	marker	of	cell	necrosis	and	treatment	response	in	tumors.	Proc	Natl	Acad	Sci	U	S	A	2009;106:19801-19806.	12.	 Simpson	 RJ,	 Brindle	 KM,	 Campbell	 ID.	 Spin	 echo	 proton	 NMR	 studies	 of	 the	metabolism	of	malate	and	fumarate	in	human	erythrocytes:	dependence	on	free	NAD	levels.	Biochim	Biophys	Acta	1982;707:191-200.	13.	 Witney	TH,	Kettunen	MI,	Hu	D-E,	Gallagher	FA,	Bohndiek	SE,	Napolitano	R,	Brindle	KM.	 Detecting	 treatment	 response	 in	 a	 model	 of	 human	 breast	 adenocarcinoma	 using	hyperpolarised	[1-13C]pyruvate	and	[1,4-13C2]fumarate.	Br	J	Cancer	2010;103:1400-1406.	14.	 Yogev	O,	Yogev	O,	 Singer	E,	 Shaulian	E,	Goldberg	M,	Fox	TD,	Pines	O.	Fumarase:	 a	mitochondrial	metabolic	 enzyme	and	a	 cytosolic/nuclear	 component	of	 the	DNA	damage	response.	PLoS	Biol	2010;8:e1000328.	
	 20	
15.	 Yogev	 O,	 Naamati	 A,	 Pines	 O.	 Fumarase:	 a	 paradigm	 of	 dual	 targeting	 and	 dual	localized	functions.	FEBS	J	2011;278:4230-4242.	16.	 Quastel	JH.	The	action	of	dyestuffs	on	enzymes.	II.	Fumarase.	Biochem	J	1931;25:898-913.	17.	 Tanaka	KR,	Valentine	WN.	Fumarase	activity	of	human	leukocytes	and	erythrocytes.	Blood	1961;17:328-333.	18.	 Brown	FF,	Campbell	ID,	Kuchel	PW,	Rabenstein	DL.	Human	erythrocyte	metabolism	studies	by	1H	spin	echo	NMR.	FEBS	Lett	1977;82:12-16.	19.	 Pagès	G,	 Kuchel	 PW.	FmRα	 analysis:	 rapid	 and	 direct	 estimation	 of	 relaxation	 and	kinetic	 parameters	 from	 dynamic	 nuclear	 polarization	 time	 courses.	 Magn	 Reson	 Med	2015;73:2075-2080.	20.	 Kuchel	PW,	Naumann	C,	Puckeridge	M,	Chapman	BE,	Szekely	D.	Relaxation	times	of	spin	 states	of	 all	 ranks	and	orders	of	quadrupolar	nuclei	 estimated	 from	NMR	z-spectra:	Markov	chain	Monte	Carlo	analysis	applied	to	7Li+	and	23Na+	in	stretched	hydrogels.	J	Magn	Reson	2011;212:40-46.	21.	 Pagès	 G,	 Puckeridge	 M,	 Liangfeng	 G,	 Tan	 YL,	 Jacob	 C,	 Garland	 M,	 Kuchel	 PW.	Transmembrane	 exchange	 of	hyperpolarized	 13C-urea	 in	 human	 erythrocytes:	 subminute	timescale	kinetic	analysis.	Biophys	J	2013;105:1956-1966.	22.	 Wolfram	S.	The	Mathematica	Book.	5th	ed.	Champaign:	Wolfram	Media;	2003.	1488	p.	23.	 Nordmann	 J,	 Nordmann	 R.	 Organic	 acids	 in	 blood	 and	 urine.	 Adv	 Clin	 Chem	1961;4:53-120.	24.	 Hummel	 JP.	 The	 fluorometric	 determination	 of	 malic	 acid.	 J	 Biol	 Chem	1949;180:1225-1228.	25.	 Puckeridge	 M,	 Chapman	 BE,	 Conigrave	 AD,	 Grieve	 SM,	 Figtree	 GA,	 Kuchel	 PW.	Stoichiometric	relationship	between	Na+	ions	transported	and	glucose	consumed	in	human	erythrocytes:	 Bayesian	 analysis	 of	 23Na	 and	 13C	 NMR	 time	 course	 data.	 Biophys	 J	2013;104:1676-1684.	26.	 Shishmarev	D,	Chapman	BE,	Naumann	C,	Mamone	S,	Kuchel	PW.	1H	NMR	z-spectra	of	acetate	methyl	in	stretched	hydrogels:	quantum-mechanical	description	and	Markov	chain	Monte	Carlo	relaxation-parameter	estimation.	J	Magn	Reson	2015;250:29-36.	27.	 Nelson	DL,	Cox	MM.	Lehninger	Principles	of	Biochemistry.	5th	ed.	New	York:	W.H.	Freeman	and	Company;	2008.	1100	p.	28.	 Cornish-Bowden	 A.	 Fundamentals	 of	 enzyme	 kinetics.	 4th	 ed.	 Weinheim:	 Wiley-Blackwell;	2012.	510	p.	29.	 Endre	ZH,	Kuchel	PW,	Chapman	BE.	Cell	volume	dependence	of	 1H	spin-echo	NMR	signals	in	human	erythrocyte	suspensions:	the	influence	of	in	situ	field	gradients.	Biochim	Biophys	Acta	1984;803:137-144.	30.	 Pagès	 G,	 Tan	 YL,	 Kuchel	 PW.	 Hyperpolarized	 [1,13C]pyruvate	 in	 lysed	 human	erythrocytes:	 effects	 of	 co-substrate	 supply	 on	 reaction	 time	 courses.	 NMR	 Biomed	2014;27:1203-1210.	31.	 Pagès	G,	Kuchel	PW.	Mathematical	modeling	and	data	analysis	of	NMR	experiments	using	hyperpolarized	13C	metabolites.	Magn	Reson	Insights	2013;6:13-21.	32.	 Bankson	 JA,	 Walker	 CM,	 Ramirez	 MS,	 Stefan	 W,	 Fuentes	 D,	 Merritt	 ME,	 Lee	 J,	Sandulache	VC,	Chen	Y,	Phan	L,	Chou	P-C,	Rao	A,	Yeung	S-CJ,	Lee	M-H,	Schellingerhout	D,	Conrad	 CA,	 Malloy	 C,	 Sherry	 AD,	 Lai	 SY,	 Hazle	 JD.	 Kinetic	 modeling	 and	 constrained	
	 21	
reconstruction	 of	 hyperpolarized	 [1-13C]-pyruvate	 offers	 improved	metabolic	 imaging	 of	tumors.	Cancer	Res	2015;75:4708-4717.	33.	 Simpson	 RJ,	 Brindle	 KM,	 Brown	 FF,	 Campbell	 ID,	 Foxall	 DL.	 Studies	 of	 lactate	dehydrogenase	in	the	purified	state	and	in	intact	erythrocytes.	Biochem	J	1982;202:581-587.	34.	 Scott	EM,	Powell	R.	Kinetics	of	the	fumarase	system.	J	Am	Chem	Soc	1948;70:1104-1107.	35.	 Borsook	 H,	 Schott	 HF.	 The	 role	 of	 the	 enzyme	 in	 the	 succinate-enzyme-fumarate	equilibrium.	J	Biol	Chem	1931;92:535-557.	36.	 Massey	V.	Studies	on	fumarase.	2.	The	effects	of	inorganic	anions	on	fumarase	activity.	Biochem	J	1953;53:67-71.	37.	 Day	SE,	Kettunen	MI,	Gallagher	FA,	Hu	D-E,	Lerche	M,	Wolber	J,	Golman	K,	Ardenkjaer-Larsen	 JH,	 Brindle	 KM.	 Detecting	 tumor	 response	 to	 treatment	 using	 hyperpolarized	 13C	magnetic	resonance	imaging	and	spectroscopy.	Nat	Med	2007;13:1382-1387.	38.	 Rytting	 M,	 Worth	 L,	 Jaffe	 N.	 Hemolytic	 disorders	 associated	 with	 cancer.	Hematol/Oncol	Clin	1996;10:365-376.	39.	 Lohrmann	H-P,	Adam	W,	Heymer	B,	Kubanek	B.	Microangiopathic	hemolytic	anemia	in	metastatic	carcinoma:	report	of	eight	cases.	Ann	Intern	Med	1973;79:368-375.	40.	 Lechner	 K,	 Obermeier	 HL.	 Cancer-related	 microangiopathic	 hemolytic	 anemia:	clinical	and	laboratory	features	in	168	reported	cases.	Medicine	2012;91:195-205.	41.	 Antman	 KH,	 Skarin	 AT,	 Mayer	 RJ,	 Hargreaves	 HK,	 Canellos	 GP.	 Microangiopathic	hemolytic	anemia	and	cancer:	a	review.	Medicine	1979;58:377-384.	42.	 Dumez	H,	Guetens	G,	De	Boeck	G,	Highley	MS,	Maes	RAA,	van	Oosterom	AT,	de	Bruijn	EA.	The	relevance	of	therapeutic	drug	monitoring	in	plasma	and	erythrocytes	in	anti-cancer	drug	treatment.	Clin	Chem	Lab	Med	2004;42:1219-1227.	43.	 Schauf	B,	Schweizer	N,	 Solomayer	E,	Wallwiener	D,	Huober	 J.	Direct	 toxic	 effect	of	cytostatic	drugs	on	erythrocytes	as	possible	reason	for	chemotherapy-induced	anemia.	J	Clin	Oncol	2004;22:781-781.	
 
 
Figure 1. A representative time course of 1H spin-echo NMR spectra of hemolysates. The 
spectra were acquired at 37˚C every 5 s over a period of ~10 min upon injection of a fumarate 
solution (final Ht = 43.5% and 11.4 mM fumarate). For clarity, only every tenth spectrum is 
shown. The signal from the fumarate is at 6.49 ppm; the signals from malate are at 2.33, 2.64 
and 4.27 ppm; the resonance at 1.30 ppm was assigned to the methyl group of lactate. 
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Figure 2. Fumarase activity in fresh hemolysates (Ht = 43.5%), recorded using 1H spin-echo 
NMR spectra at 37˚C every 5 s over the course of ~20 min. Temporal evolution of the 
calculated concentrations of fumarate (blue dots) and malate (red dots) were plotted. The time 
courses were obtained by injection of (A) 22.8 mM and (B) 11.4 mM fumarate. Solid lines are 
nonlinear regression analysis fits of the Michaelis-Menten model. The estimated best-fit 
parameter value were: = 5.9 ± 0.3 mmol (L RBC)-1 min-1;  = 16.0 ± 0.6 mmol (L 
RBC)-1 min-1; = 3.9 ± 0.3 µM; = 25.6 ± 1.0 µM; and !"# = 2.4 ± 0.3. 
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Figure 3. A fumarase-reaction time course of 1H spin-echo NMR spectra in whole RBCs. The 
spectra were acquired at 37˚C every 5 s over a period of ~40 min upon injection of 2.0 mL of 
the fumarate solution into an RBC suspension (final Ht = 43.5% and 44.8 mM fumarate). After 
~10 min from the start of the reaction, 1.0 mL of Triton X-100 was injected into the medium. 
The relevant peak assignments are indicated above the top spectrum. For clarity, every tenth 
spectrum is shown and the amplitude of the fumarate peak was adjusted to be the same in all 
shown spectra. 
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Figure 4. Representative 13C-NMR spectra of hemolysates, acquired at 37˚C every 1 s over a 
period of 256 s, after injection of a hyperpolarized solution of [1,4-13C]fumarate (final Ht = 
42.5% and 22.2 mM fumarate). For clarity, every fifth spectrum is shown. The truncated signal 
from the hyperpolarized [1,4-13C]fumarate is at 176.1 ppm, the signals from carbon-1 and 
carbon-4 of [1,4-13C]malate are at 182.5 and 181.3 ppm, respectively. 
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Figure 5. 13C-NMR RD-DNP time courses obtained after injection of hyperpolarized [1,4-
13C]fumarate solution into a fresh hemolysate (final Ht = 42.5% and 22.2 mM fumarate). The 
decaying fumarate signal was normalized to a maximum of 1.0, while the signal from L-malate 
was scaled up by a factor of 20 to make it more visible on the given scale. The various lines 
and arrows were used in FmRα analysis as described in the text. They yielded the estimates of 
the average T1 = ~18 s and k1 = ~1.4 × 10-3 s-1. 
 
Figure 6. A kinetic scheme of the fumarase reaction in the 13C-NMR RD-DNP experiment. 
The asterisks indicate hyperpolarized (‘labelled’) fumarate and malate species. The scheme 
served as a basis for modeling of the kinetics equations (Equations 7-10), which were used for 
the quantitative description of the RD-DNP experiment. 
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Figure 7. MCMC fitting analysis of 13C-NMR RD-DNP data. (A) Time course of the nominal 
concentrations of the hyperpolarized fumarate (Fum*; blue dots), hyperpolarized malate ( 
Mal*; red dots) and the fitted curves (solid black lines). 2.0 mL of hyperpolarized [1,4-
13C]fumarate solution was injected into 2.0 mL of fresh hemolysate containing 0.25 mL of 
2H2O saline (154 mM NaCl). The MCMC analysis was used to fit the numerical solution of 
Equations 13-16 to the data and returned the following values of parameters (after constraining 
α = 4o, Keq = 2.4, and = 3.9 µM):  = 20.7 ± 0.5 s;  = 19.1 ± 3.4 s;  = 4.0 ± 
0.8 mmol (L RBC)-1 min-1;  = 13.0 ± 4.7 mmol (L RBC)-1 min-1; and initial concentration 
of [Fum*](0) = 20.9 ± 0.3 mM. (B) The MCMC ‘sensitivity analysis’, presented as selected 
histograms illustrating the statistical variation in the fitted parameters (see text). 
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